Goldenberg D M
Immunol Today. 1989 Sep;10(9):286-8. doi: 10.1016/0167-5699(89)90082-0.
The fourth international conference on monoclonal antibody immunoconjugates for cancer heard of great progress in the area of radioimmunoconjugates, and of continued research into the potential of immunotoxins, chemoimmunoconjugates and anti-immunoglobulin therapy as potential cancer therapies.
第四届癌症单克隆抗体免疫缀合物国际会议获悉,放射免疫缀合物领域取得了重大进展,并且对免疫毒素、化学免疫缀合物和抗免疫球蛋白疗法作为潜在癌症治疗方法的潜力的研究仍在继续。